Professional services
Ended Awarded Last action
- Contract number
- 75F40121F19187
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,638,511
Award facts
- Contract value 54% obligated
-
- $3,638,510.90 Current, with exercised options
- $6,723,960.94 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,660,406 | |
| Other Administrative Action | $67,565 | |
| Other Administrative Action | $2,229,944 | |
| Original award | $3,001,408 |
About this award
This federal contract award is for professional services provided by Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation, to the Food and Drug Administration (FDA), a civilian agency. The contract is a Blanket Purchase Agreement (BPA) Call under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle, with a firm fixed price pricing type and a ceiling value of $6,723,960.94. The contract has a period of performance through September 20, 2023 and does not have a set-aside designation. Brillient Corporation has been awarded numerous federal contracts, including a $55.3 million BPA with the Department of the Treasury Internal Revenue Service and a $58.5 million indefinite delivery contract with the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. Additionally, Brillient holds a position on the GSA's $999.9 billion One Acquisition Solution for Integrated Services (OASIS) contract vehicle.
Quick answers
Who was awarded contract 75F40121F19187?
75F40121F19187 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on August 19, 2021.
How much is contract 75F40121F19187 worth?
The government has obligated $3,638,511 on 75F40121F19187. Its potential value, with all options, is $6,723,961.
Is contract 75F40121F19187 an order under another contract?
Yes. 75F40121F19187 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19187 competed?
The extent of competition for 75F40121F19187 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award